Sanofi annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Sanofi Free Cash Flow (FCF) History (SNY)
Sanofi reported €7.21B in free cash flow for fiscal 2025, an increase of 22.53% from the previous fiscal year, with a free cash flow margin of 16.53%.
View full Sanofi company overviewSanofi free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | €7.21B | €1.33B | +22.53% | +16.53% |
| 2024 | 2024-12-31 | €5.89B | −€1.47B | −19.94% | +14.33% |
| 2023 | 2023-12-31 | €7.35B | −€1.07B | −12.72% | +19.44% |
| 2022 | 2022-12-31 | €8.42B | −€56.0M | −0.66% | +22.37% |
| 2021 | 2021-12-31 | €8.48B | €3.14B | +58.93% | +22.45% |
| 2020 | 2020-12-31 | €5.33B | −€593.0M | −10.00% | +14.80% |
| 2019 | 2019-12-31 | €5.93B | — | — | +16.41% |
Sanofi quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Sanofi free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from €5.33B to €7.21B, a compound annual growth rate of 6.21%.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Sanofi filings at SEC.gov ↗